Pfizer ’s COVID revenues have dropped off along with attention to the pandemic

Pfizer PFE updated its yearly sales guidance for Comirnaty, the COVID-19 vaccine it developed with BioNTech BNTX, saying it now expects $13.5 billion in revenue this year. The shot brought in $37.8 billion in 2022. The drugmaker also lowered revenue expectations for its COVID antiviral, Paxlovid,…#comirnaty #bntx
Source: Reuters: Health - Category: Consumer Health News Source Type: news